Conference
A Phase II Study of Dovitinib in Previously-Treated Malignant Pleural Mesothelioma: The Ontario Clinical Oncology Group DOVE-M Trial
Authors
Laurie SA; Hao D; Leighl N; Goffin J; Khomani A; Filion M; Pond GR; Levine MN
Volume
10
Pagination
pp. S352-S352
Publisher
ELSEVIER SCIENCE INC
Publication Date
September 1, 2015
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
Issue
9
ISSN
1556-0864